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Abstract Silver nanoparticles were synthesized in the 
protein-polymer matrices of two different ratios to 
obtain a stringent control over the morphology. UV-
visible spectrophotometry showed a single plasmon 
resonance peak at 416nm and 418nm respectively, 
confirming the formation of silver nanoparticles. X-ray 
diffractometry confirmed that the peaks matched with 
that of the reference silver. Both confocal microscopy 
and FEG-SEM confirmed the uniform morphology of 
the synthesized particles dependent on the template 
ratio. Doubling the protein-polymer concentration 
results in greater stability, more nucleation sites and 
hence restricted growth. Photoluminescence of the 
sample in the doubled matrix was found to be much 
greater at any given wavelength, meaning the flexibility 
and rigidity of interacting molecules affects the 
luminescence signal. The interaction in turn is 
dependent on the proximity of the proteins and polymer 
in the dispersion that forms a template and dictates the 
synthesis. 
 






Organic-inorganic nanocomposites have attracted 
immense attention because of their potential to combine 
the features of polymeric materials with those of 
inorganic materials. Colloidal silver nanoparticles 
(AgNPs) synthesized in a protein-polymer matrix have 
numerous applications as biosensors, antimicrobial 
agents, catalysts and as new generation light weight 
electronic devices [1-2]. A battery of techniques are 
available in the literature to synthesize AgNPs in aqueous 
as well as in non-aqueous, media [3-9]. The general 
philosophy of controlled synthesis of metal nanoparticles 
from its salt solution is based on designing the right 
template, templating agents in addition to controlling 
morphology and also preventing the nanoparticles from 
agglomeration [10-12]. Examples include the work of Rita 
et al. [13], who reported the synthesis of AgNPs using 
hydroquinone and sodium citrate as the reducing agent 
with neutral polymers poly (vinyl-pyrrolidone) (PVP) 
and poly (vinyl alcohol) (PVA) as stabilizers. Soloman et 
al. [14] synthesized AgNPs by reducing silver nitrate with 
sodium borohydride without using any surfactant 
leading to aggregation. Kim et al. [15] chose various silver  
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salts as the starting material and examined the effect of an 
initial precursor on the rate of nanoparticle formation. 
They found that by using silver salts, such as silver 
tetrafluoroborate (AgBF4), silver hexafluorophosphate 
(AgPF6) and silver perchlorate (AgClO4), the reaction 
proceeded rapidly in the beginning and then slowed, 
whereas in the case of silver nitrate (AgNO3) the reaction 
rate was slower but constant. Prasad and co-workers [16] 
used sophorolipids for the synthesis and stabilization of 
AgNPs. In comparison to in situ reduction of silver ions in 
aqueous solution, a polymer matrix-mediated reduction 
of silver ions has been found to be more suitable for the 
synthesis of polymer-silver nanocomposite particles for 
various biomedical applications [17]. Matrix mediated 
synthesis of metal nanoparticles, a derivative of 
biomineralization termed “biomimetic synthesis”, yields 
nanoparticles with stringent control over shape and size 
[18, 19]. Various groups have reported in situ synthesis of 
AgNPs in PVA with and without another reducing agent 
[20-22]. Clemensen et al. studied the effect of silver ion 
concentration on PVA mediated synthesis of AgNPs [23]. 
Here we have used a combination of PVA (P), collagen 
(C) and Bovine Serum Albumin (BSA) (B) in two different 
concentrations for the synthesis. The idea of using three 
ligands is to improve stability and enhance functionality; 
the mutual interaction of the protein-polymer is 
dependent on their concentration and we have optimized 
a certain combination for our reactions. We have reported 
the usage of the same combination for the synthesis of 
ferrofluids and magnetic hydroxyapatite [24-25]. “In situ 
synthesis of hydroxyapatite on fluidic IONPs in ambient 
condition” communicated to, J. Mater. Sci.-Mater. Med .. 
To the best of our knowledge, no one else has used the 
above mentioned combination for the synthesis of AgNPs 
that also plays a dual role of a template and a stabilizer.  
 
2. Material and Methods  
 
2.1 Materials 
AgNO3 was purchased from Nice chemicals Ltd. and 
PVA(P) (MW 95000, degree of hydrolysis 90%) from 
Acros Organics, sodium hydroxide and dextrose from 
MERCK, Mumbai, India, Collagen (C ) from SIGMA 
ALDRICH, St Louis, USA; BSA(B)- fraction V (bovine 
serum albumin) from ACROS ORGANICS, New Jersey, 
USA. All the chemicals were of analytical grade and used 
without further purification. Double distilled water was 
used throughout the experiment.  
 
2.2 Synthesis of Ag CPB 
 
C 0.01%, P 0.01% and B 0.001% were dissolved in 20ml 
(each separately) in Phosphate Buffer Saline and then 
mixed together and allowed to equilibrate for six hours. 
2mM AgNO3 solution was prepared in 40ml double 
distilled water. AgNO3 solution was added to the above 
mixture, the volume was made up to 100ml. After one 
and a half hours of stirring at 300rpm, 2ml of 4M NaOH 
was added drop wise to the sample in stirring condition 
and the colour change was observed from colourless to a 
brown colour, due to formation of silver oxide at pH 11.5. 
1ml of 1M dextrose was added to the mixture and a dark 
grey colour was formed due to the reduction of silver 
oxide to silver. For the synthesis of Ag CPB D the 
concentrations were doubled to C 0.02%, P 0.02% and B 
0.002% keeping other parameters and steps the same as in 
the synthesis of Ag CPB. The synthesized nanofluids 
were centrifuged and dialyzed using cellulose membrane, 
HIMEDIA, Mumbai, India, against double distilled water 
to remove the by-products and the dialyzed fluid was 
used for characterization. 
 
2.3 Characterization 
The visible light absorption of the samples was recorded 
using a Cary 50 Bio UV-Vis spectrophotometer by 
VARIAN. Phase identification of the samples was 
conducted at room temperature x-ray diffraction in D8 
DISCOVER BRUKER Diffractometer, AXS GmbH, 
Germany, operated at 40KV with CuKα radiation (λ=1.5418 
Ǻ) within a scanning range of 20o-90o (2Ө) at a step size of 
0.02o/step and scanning speed of 1sec/step. The shape and 
morphology of the nanoparticles were recorded in FEG 
SEM Nova Nano SEM 430 operated at 15 kV. Images of 
liquid samples were recorded using a ZEISS CLSM 700 
confocal microscope in both differential interference 
contrast (DIC) and fluorescent mode with no fluorophores. 
A drop of sample was sandwiched with cover slips on 
glass micro slides and observed under the microscope. 
Hydrodynamic diameter (DH), zeta potential and 
polydispersity index (PDI) was measured by a zetasizer 
DLS NANO 100, MALVERN INSTRUMENTS, USA. The 
hydrodynamic radius (RH = DH/2) was calculated from the 
diffusion coefficient using the Stokes-Einstein equation,  
 
 
Where, K is the Boltzmann constant, T is the temperature, 
η is the medium viscosity and f=6πηRH is the frictional 
coefficient for a hard sphere in a viscous medium. The 
data was measured using the back scattering technique at 
an angle of 173o. Photoluminescence was recorded using 
a F-4500 fluorescence spectrophotometer from HITACHI. 
Drug binding and release were studied using the drug 
methotrexate, a drug used in the therapy of cancer.  
 
3. Results and Discussions 
 
3.1 UV-vis Spectrophotometry and X-ray diffractometry 
 
UV visible spectra of samples were recorded in the range 
of 300 to 700nm as shown in Figure 1, post seven times 
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dilution with DDW (double distilled water). There was 
only one characteristic surface plasmon absorption peak 
at 416nm for Ag CPB D and at 418nm for Ag CPB. 
According to Mie’s theory anisotropic particles show two 
or three bands dependent on their shape, the fact that 
there is only one distinct peak proves a stringent control 
over nucleation and subsequent growth. The inset shows 
XRD pattern of both nanofluids indexed w.r.t. standard 
silver (JCPDS card no. 87-0720). Characteristic peaks 
corresponding to the Bragg planes (111), (200), (220), 
(311), (222) confirm the formation of silver nanoparticles. 
The crystallite size of Ag CPB was 46.95 nm and that of 
Ag CPB D was 21.16 nm corresponding to the 100% peak, 
on doubling the concentration of the protein and polymer 
the size of the nanoparticles were reduced with a slight 
shift in every peak. 
 
 
Figure 1. UV-Vis spectroscopy of the Ag CPB and Ag CPB D 
shows peaks at 418nm and416nm respectively. Inset shows the 
XRD peaks of both that confirm the formation of AgNPs 
 
3.2 Confocal Microscopy and FEG SEM 
 
The final morphology and crystallinity of the nanofluid is 
dependent on the concentration of the protein and 
polymer added. The functional groups like amine-(NH2), 
carboxyl (–COOH), and hydroxyl (-OH) not only 
stabilizes the colloid, but also increases the number of 
nucleation sites. The matrix of polymer PVA and the two 
proteins BSA and Collagen forms a well-organized matrix 
with specific nucleation sites for AgNPs seen in the 
confocal differential interference contrast (DIC) image. 
This is similar to the biomineralization process where 
controlled growth of inorganic component takes place 
inside an organic matrix [25] as is evident from figure 2.  
 
The multitude of non-covalent interactions between the 
organic and inorganic network results in uniform 
morphology, spherical nanoparticles were seen in FEG 
SEM in both the samples. The size only reduced due to an 
increase in nucleation sites with the doubling of the matrix 
constituents. Green auto fluorescence was observed 
corresponding to an Alexa Flour AF488 filter in all the 
samples in confocal micrographs. Fluorescence at certain 
defined positions clearly shows site-specific nucleation in 
both, Ag CPB at greater distances as compared to the close 
tight fit of Ag CPB D that reduces size.  
 
 
Figure 2. shows the confocal images in differential interference 
contrast (DIC) mode and fluorescence mode (a), (b) control (c) 
and (d) Ag CPB, (e) and (f) Ag CPB D. The inset of fig (c) and (e) 
shows the FEG SEM image of AgNPs, spherical in shape for 
both. 
 
3.3 Drug binding and release and dynamic light scattering 
 
Drug binding and release of the samples, using the 
Methotrexate drug, was studied by measuring 
absorbance at 305nm. The absorbance was recorded every 
hour for a total period of seven hours both for binding 
and post dialysis using 0.05% NaCl for release (Ag CPB 
nanoparticles do not cross the dialysis membrane while 
methotrexate does so). Both samples have equally good 
binding properties with the drug but when the release 
profile was studied it was found that Ag CPB D releases 
the drug in a more controlled way compared to Ag CPB, 
which shows immediate release of the drug as seen in 
figure 3. The entrapment efficiency for Ag CPB and Ag 
CPB D was found to be 80.4% and 86%, respectively 
calculated using: 
 
% Entrapment efficiency  =  Amount of drug loaded × 100 
                  Initial amount of drug added into the system 
 
This shows that doubling the template concentration does 
not necessarily double the entrapment. That Ag CPB D 
has a controlled release profile is an indicator that it has 
the potential of sustained release of the drug, which is a 
requirement in the release of cancer drugs. These two 
formulations of nanofluids can be used for two different 
purposes; Ag CPB D for sustained therapy and Ag CPB 
where the drug is needed quickly. 
 
The DH of Ag CPB was found to be 70.26nm, zeta 
potential -28.7mV and PDI 0.259 as compared to 92.04nm, 
-11.9mV and 0.207 of Ag CPB D. These fluids are  
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Figure 3. The above graph depicts the time versus absorbance for the binding and release of the drug methotrexate to the sample Ag 
CPB in black and Ag CPB D in red 
 
stabilized with the protein-polymer interaction, but there 
is a certain optimum ratio of the proteins and the polymer 
that is needed for the best stability and CPB seems to be 
better than CPB D in terms of stability. As seen from FEG-
SEM there is fusion of the uniform-sized globules 
approximately 100nm in size, when one doubles the 
protein-polymer concentration and that could be the 
reason for the lesser stability of the fluids. These results 
are in good agreement with the UV-visible results. The 
hydrodynamic size increases with a double CPB 
concentration, because of the increased bonding 
possibilities with water molecules. 
 
 
Figure 4. Comparison of the emission intensity variation for Ag 




The two samples Ag CPB and Ag CPB D were excited in 
the range of 340nm to 400nm and photoluminescence 
emission was recorded and plotted against intensity for 
both samples. Luminescence of Ag CPB D was found to 
be almost thrice compared to the Ag CPB at the same  
 
wavelength. The nature of the chemical structure of a 
molecule in terms of flexibility and rigidity is of major 
influence on the luminescence signal. Molecules that have 
a high degree of flexibility will tend to decrease 
luminescence due to higher collisional probability. Rigid 
structures have lower probability of collisions and thus 
have more luminescence potential as seen in figure 4. 
When we double the protein-polymer concentration, we 
are essentially increasing the rigidity and hence these 




The in situ reduction of silver ions in protein-polymer 
matrix is an attractive process having industrial potential 
as it is easily scalable. The mechanism of synthesis of 
silver nanoparticles using PVA with collagen and with 
BSA, individually or in combination, is well documented 
in the literature. Previous, studies with only PVA shows 
that its concentration (which is usually quite high), plays 
a major role in determining the dimensions, as well as the 
stability of the silver colloidal solution. This new 
combination of the matrix has only been reported by our 
group. The results prove that the Ag CPB D and Ag CPB 
though both show stability and superior characteristics, 
proving that in addition to ferrofluids and magnetic 
hydroxyapatite, the matrix is also good for Ag 
nanoparticles. This study shows that using a combination 
of proteins and polymer we can not only decrease the 
total concentration of the organic content but also 
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